Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  UCB SA    UNC

UCB SA (UNC)

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Deutsche Boerse Ag
07/23/2015 07/24/2015 07/27/2015 07/28/2015 07/29/2015 Date
71.015(c) 70.665(c) 70.228(c) 66.365(c) 66.855(c) Last
50 597 0 36 34 Volume
+1.14% -0.49% -0.62% -5.50% +0.74% Change
More quotes
Financials (€)
Sales 2015 3 624 M
EBIT 2015 518 M
Net income 2015 282 M
Debt 2015 1 515 M
Yield 2015 1,71%
Sales 2016 3 895 M
EBIT 2016 648 M
Net income 2016 386 M
Debt 2016 1 372 M
Yield 2016 1,84%
PER 2015 36,59
PER 2016 31,14
EV / Sales 2015 4,01x
EV / Sales 2016 3,69x
Capitalization 13 001 M
More Financials
Company
UCB SA is a biopharmaceutical company that engages in the research, development and commercialization of innovative drugs in the fields of central nervous system and immunology disorders.It focuses on the discovery and development of innovative medicines and solutions to transform the lives of... 
Sector
Pharmaceuticals
Calendar
07/31 | 01:00amEarnings Release
More about the company
Surperformance© ratings of UCB SA
Trading Rating : Investor Rating :
More Ratings
Latest news on UCB SA
07/06 UCB : DEA Issues Notice on Importer of Controlled Substances Application from Kr..
07/06 UCB : Importer of Controlled Substances Application: Kremers Urban Pharmaceutica..
06/24 CIPLA : Lupin readies Rs7,500 cr chest for buyouts
06/01 CIPLA : LUPIN, CIPLA BID FOR UCB's $1 BILLION US GENERICS UNIT
06/01 Lupin, cipla bid for ucb's $1 billion generics unit
05/27 UCB : Patent Issued for Pharmaceutical Composition Comprising Rotigotine Salts (..
05/04 UCB : ex-dividend day for annual dividend
04/02 DR REDDY LABORATORIES : Labs to Acquire Brands Portfolio of UCB for USD128 Milli..
More news
Sector news : Biopharmaceuticals
08:07aDJAstraZeneca Boosted by Licensing Deals -- 2nd Update
07:45a ASTRAZENECA : Ups Revenue Guidance As First Half Profit Falls (UPDATE)
07:39a ASTRAZENECA : IN THE KNOW: Analysts Positive As AstraZeneca Interims Beats Forec..
More sector news : Biopharmaceuticals
Comments 
Advertisement
Chart UCB SA
Duration : Period :
UCB SA Technical Analysis Chart | UNC | BE0003739530 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions